369 related articles for article (PubMed ID: 27063171)
1. [Correlation of Tp-e interval and Tp-e/Q-T ratio with malignant ventricular arrhythmia in patients with implantable cardioverter-defibrillator for primary prevention].
Zhu TY; Teng SE; Chen YY; Liu SR; Meng SR; Peng J
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Mar; 36(3):401-4. PubMed ID: 27063171
[TBL] [Abstract][Full Text] [Related]
2. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
[TBL] [Abstract][Full Text] [Related]
3. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
[TBL] [Abstract][Full Text] [Related]
4. Long-term incidence of malignant ventricular arrhythmia and shock therapy in patients with primary defibrillator implantation does not differ from event rates in patients treated for survived cardiac arrest.
Backenköhler U; Erdogan A; Steen-Mueller MK; Kuhlmann C; Most A; Schaefer C; Stertmann W; Waas W; Tillmanns H; Waldecker B
J Cardiovasc Electrophysiol; 2005 May; 16(5):478-82. PubMed ID: 15877617
[TBL] [Abstract][Full Text] [Related]
5. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
[TBL] [Abstract][Full Text] [Related]
6. Tpeak - Tend and Tpeak - Tend /QT ratio as markers of ventricular arrhythmia risk in cardiac resynchronization therapy patients.
Barbhaiya C; Po JR; Hanon S; Schweitzer P
Pacing Clin Electrophysiol; 2013 Jan; 36(1):103-8. PubMed ID: 23106253
[TBL] [Abstract][Full Text] [Related]
7. Changes and predictive value of dispersion of repolarization parameters for appropriate therapy in patients with biventricular implantable cardioverter-defibrillators.
Lellouche N; De Diego C; Akopyan G; Boyle NG; Mahajan A; Cesario DA; Wiener I; Shivkumar K
Heart Rhythm; 2007 Oct; 4(10):1274-83. PubMed ID: 17905332
[TBL] [Abstract][Full Text] [Related]
8. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
[TBL] [Abstract][Full Text] [Related]
9. Electrocardiographic Markers of Appropriate Implantable Cardioverter-Defibrillator Therapy in Young People with Congenital Heart Diseases.
Benítez Ramos DB; Cabrera Ortega M; Castro Hevia J; Dorantes Sánchez M; Alemán Fernández AA; Castañeda Chirino O; Cruz Cardentey M; Martínez López F; Falcón Rodríguez R
Pediatr Cardiol; 2017 Dec; 38(8):1663-1671. PubMed ID: 28871362
[TBL] [Abstract][Full Text] [Related]
10. [Negative result of microvolt T-wave alternans test is helpful in scheduling the order of cardioverter-defibrillator implantation in primary prevention of sudden cardiac death in individuals with the left ventricular systolic dysfunction].
Daniłowicz-Szymanowicz L; Szwoch M; Raczak J; Raczak G
Pol Merkur Lekarski; 2012 Oct; 33(196):193-7. PubMed ID: 23272605
[TBL] [Abstract][Full Text] [Related]
11. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.
Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS
Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754
[TBL] [Abstract][Full Text] [Related]
12. Predictive power of T-wave alternans and of ventricular gradient hysteresis for the occurrence of ventricular arrhythmias in primary prevention cardioverter-defibrillator patients.
Man S; De Winter PV; Maan AC; Thijssen J; Borleffs CJ; van Meerwijk WP; Bootsma M; van Erven L; van der Wall EE; Schalij MJ; Burattini L; Burattini R; Swenne CA
J Electrocardiol; 2011; 44(4):453-9. PubMed ID: 21704222
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy.
Wang W; Lian Z; Rowin EJ; Maron BJ; Maron MS; Link MS
Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28314849
[TBL] [Abstract][Full Text] [Related]
14. T-peak to T-end interval for prediction of ventricular tachyarrhythmia and mortality in a primary prevention population with systolic cardiomyopathy.
Rosenthal TM; Stahls PF; Abi Samra FM; Bernard ML; Khatib S; Polin GM; Xue JQ; Morin DP
Heart Rhythm; 2015 Aug; 12(8):1789-97. PubMed ID: 25998895
[TBL] [Abstract][Full Text] [Related]
15. Tpeak-Tend interval during therapeutic hypothermia can predict upcoming ventricular fibrillation in subjects with aborted arrhythmic sudden cardiac death: 3-years follow-up results.
Yoon N; Hong S; Glass A; Kim SS; Kim MC; Cho JY; Lee KH; Sim DS; Yoon HJ; Kim KH; Hong YJ; Park HW; Kim JH; Ahn Y; Jeong M; Park JC; Cho JG
Europace; 2017 Dec; 19(suppl_4):iv17-iv24. PubMed ID: 29220423
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) trial.
Kloppe A; Proclemer A; Arenal A; Lunati M; Martìnez Ferrer JB; Hersi A; Gulaj M; Wijffels MC; Santi E; Manotta L; Mangoni L; Gasparini M
Circulation; 2014 Jul; 130(4):308-14. PubMed ID: 24838360
[TBL] [Abstract][Full Text] [Related]
17. Time-dependent effect of cardiac resynchronization therapy on ventricular repolarization and ventricular arrhythmias.
Itoh M; Yoshida A; Fukuzawa K; Kiuchi K; Imamura K; Fujiwara R; Suzuki A; Nakanishi T; Yamashita S; Matsumoto A; Hirata K
Europace; 2013 Dec; 15(12):1798-804. PubMed ID: 23736809
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of implantable cardioverter-defibrillator implantation in secondary prevention of sudden cardiac death.
Boulé S; Sémichon M; Guédon-Moreau L; Drumez É; Kouakam C; Marquié C; Brigadeau F; Kacet S; Potelle C; Escande W; Souissi Z; Lacroix D; Duhamel A; Klug D
Arch Cardiovasc Dis; 2016 Oct; 109(10):517-526. PubMed ID: 27342808
[TBL] [Abstract][Full Text] [Related]
19. The predictive value of electrocardiographic polarization parameters on appropriate ICD shock in primary prevention heart failure patients.
Ozgul U; Turan OE; Baskurt AA; Yilancioglu RY; Dogdus M; Inevi UD; Ozcan EE
J Electrocardiol; 2023; 77():80-84. PubMed ID: 36347655
[TBL] [Abstract][Full Text] [Related]
20. Left ventricle remodeling predicts the recurrence of ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients for secondary prevention.
Lee WC; Chen HC; Chen YL; Tsai TH; Pan KL; Lin YS; Chen MC
BMC Cardiovasc Disord; 2016 Nov; 16(1):231. PubMed ID: 27871248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
